Through a mouse study, scientists have found that aspirin may help prevent metastases, or secondary tumors, by boosting the body’s immune response.

In a remarkable scientific breakthrough that researchers are calling a ‘eureka moment,’ a team at the University of Cambridge has potentially turned a cheap painkiller into a new weapon to fight ...

In the current study, looking at the mouse model of melanoma — an aggressive form of skin cancer ... of our findings in understanding the anti-metastatic activity of aspirin.

The findings suggest that targeting this vulnerable phase with aspirin or similar drugs could dramatically reduce the risk of cancer metastasis and recurrence, potentially changing the way we ...

Dr. Jie Yang, who carried out the researchm described the drug as a less expensive solution that is more accessible globally.

Before this, we had not been aware of the implication of our findings in understanding the anti-metastatic activity of aspirin. It was an entirely unexpected finding which sent us down quite a ...

That’s according to a new study from the University of Cambridge, which found that aspirin could reduce cancer metastatis (spread) by stimulating participants’ immune systems. The findings ...

An international research team headed by scientists at the University of Cambridge has uncovered a mechanism that may underpin how aspirin could reduce the metastasis of some cancers by preventing ...

This knowledge could be instrumental in future treatments. Combining their understanding of metastasis's weak point with recent findings on aspirin, the Cambridge research team discovered that aspirin ...

Despite the promising findings, healthcare professionals emphasize the importance of consulting with medical providers before starting any aspirin regimen. This cautionary approach stems from the ...